ENANTIGEN THERAPEUTICS
nantigen Therapeutics, Inc. is an innovative pharmaceutical company located at the Pennsylvania Biotechnology Center and striving for excellence in the discovery, development and commercialization of novel drugs to treat life-threatening infectious diseases. The primary focus is on the development of oral therapeutics for the treatment of hepatitis B.
ENANTIGEN THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.enantigen.com
Total Employee:
1+
Status:
Active
Contact:
(215) 589-6350
Email Addresses:
[email protected]
Technology used in webpage:
Nginx Peg Technic XZ.com
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Filament BioSolutions
Filament BioSolutions Inc. is a medical foods and functional foods company.
Laser Tissue Welding
Laser Tissue Welding, Inc. is a privately owned biotherapeutic company.
Pantherna Therapeutics
Pantherna Therapeutics is a privately-held biopharmaceutical company.
Pherin Pharmaceuticals.
Pherin Pharmaceuticals, Inc. is a privately held clinical stage company.
Stella Therapeutics
Stella Therapeutics, a privately held drug discovery company.
More informations about "Enantigen Therapeutics"
Enantigen Therapeutics - Crunchbase Company Profile & Funding
Enantigen Therapeutics, Inc. is a privately-held pharmaceutical company. nantigen Therapeutics, Inc. is an innovative pharmaceutical company located at the Pennsylvania Biotechnology …See details»
OnCore Biopharma Agrees to Acquire Enantigen Therapeutics
Oct 1, 2014 Enantigen Therapeutics, Inc. is a privately-held pharmaceutical company committed to the discovery, development and commercialization of novel drugs to treat life-threatening …See details»
OnCore marks milestones in mission to cure hepatitis B
Nov 12, 2014 The World Health Organization estimates that more than 780,000 people die every year due to infection. The therapies that are currently available to treat the disease work by …See details»
Enantigen Therapeutics - Ownership and Business Overview
Oct 1, 2014 Enantigen Therapeutics, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel drugs to treat life-threatening …See details»
Enantigen Therapeutics Inc - Company Profile and News
Company profile page for Enantigen Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Enantigen Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Enantigen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:HBF-0079.See details»
Enantigen Therapeutics - Crunchbase
Enantigen Therapeutics, Inc. is a privately-held pharmaceutical company.See details»
OnCore Biopharma acquires Enantigen Therapeutics - 2014-10-01 ...
OnCore Biopharma acquires Enantigen Therapeutics on 2014-10-01 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Save . …See details»
Enantigen Therapeutics - Company Profile - Tracxn
Enantigen Therapeutics - Discovery and development of novel drugs to treat infectious diseases with a focus on hepatitis B (HBV). Enantigen Therapeutics - Company Profile - Tracxn …See details»
ENANTIGEN THERAPEUTICS, INC. - VentureRadar
Find out more about ENANTIGEN THERAPEUTICS, INC. including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps …See details»
OnCore Biopharma Agrees to Acquire Enantigen Therapeutics
OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral treatments for chronic hepatitis B virus …See details»
OnCore Biopharma Acquires Enantigen Therapeutics - Mergr
Oct 1, 2014 Enantigen Therapeutics, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel drugs to treat life-threatening …See details»
Enantigen Therapeutics, Inc. - Doylestown , PA - Company Profile
Enantigen Therapeutics, Inc. CLAIM THIS BUSINESS. 3805 OLD EASTON RD DOYLESTOWN, PA 18902 Get Directions (215) 589-6315. Business Info. Founded 2008; Incorporated ; Annual …See details»
Enantigen Therapeutics - Tech Stack, Apps, Patents & Trademarks
Enantigen Therapeutics, Inc. is a privately-held pharmaceutical company.See details»
enantigen.com - Overview, News & Competitors - ZoomInfo
Enantigen.com. Business Services · <25 Employees. enantigen.com is a company that operates in the Design industry. It employs 6-10 people and has $1M-$5M of revenue. Read More. View …See details»
Two drug development experts join the Baruch S. Blumberg …
Nov 11, 2024 About the Baruch S. Blumberg Institute: An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to …See details»
OnCore Beefs Up Oral HBV Compound Portfolio with Enantigen …
Oct 1, 2014 OnCore will be taking over Enantigen's two discovery programs—one targeting inhibition of s-antigen secretion and one targeting capsid assembly inhibition—as part of the …See details»
Enantigen Therapeutics - Products, Competitors, Financials, …
Enantigen Therapeutics is a pharmaceutical company. Use the CB Insights Platform to explore Enantigen Therapeutics's full profile. Technology Vendors; Recent Research ... according to …See details»
OnCore Biopharma - Funding, Financials, Valuation & Investors
Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Enantigen Therapeutics . Oct 1, 2014 — …See details»
Enantigen Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Jan 12, 2015 Enantigen Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»